Brexpiprazole Impurity 89 CAS 15450-69-8

Description

Compared with other compounds in its class, the molecular weight of 163.17 g/mol gives Brexpiprazole Impurity 89 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Brexpiprazole Impurity 89 (CAS 15450-69-8), a pharmacopoeial impurity reference standard (molecular formula C9H9NO2, MW 163.17 g/mol) used for the identification and quantification of trace impurities in APIs.

The molecular framework of Brexpiprazole Impurity 89 (C9H9NO2) is characterized by an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Brexpiprazole Impurity 89 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com